FDA
approval
· 2024-07-11
FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Original Application (Ascend Laboratories, LLC)
Summary
FDA approved a generic fixed-dose combination of olmesartan medoxomil and hydrochlorothiazide for hypertension under ANDA 207037, manufactured by Ascend Laborat…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE)